The Versi PD Cycler System conceived and developed by Debiotech and licensed to Fresenius Medical Care receives FDA clearance
Versi™PD will begin a limited rollout in 2022 with more widespread availability planned in 2023 and beyond.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Apr 22
Versi™PD will begin a limited rollout in 2022 with more widespread availability planned in 2023 and beyond.
26 Apr 22
Suitable for use with both Apple and Android devices, the app assists users in detecting pain during the…
26 Apr 22
The new BD Horizon RealYellow 586 Reagents, developed with dye technology and AI guidance, are capable to boost…
21 Apr 22
The deal will bring the software technology of MindX and Blackrock's BCI hardware under one roof to deliver…
12 Apr 22
Funding will advance next-generation technology platform, expand R&D and manufacturing facilities, grow multidisciplinary team, and launch DNA synthesis…
08 Apr 22
OMNIgene·GUT Dx allows for the non-invasive collection of human fecal samples and the stabilization of DNA from the…
06 Apr 22
ST Set previously obtained FDA Emergency Use Authorization (EUA) to help meet increased demand for continuous renal replacement…
01 Apr 22
Fresenius Kabi purchased a majority stake in mAbxience; and acquired the specialised infusion therapy company Ivenix
31 Mar 22
The device will enhance patient access and communication between patients and ophthalmologists, collect data, and serve as a…
30 Mar 22
In the study, four participants who received Stentrode, a small mesh-like, stent-mounted electrode array, permanently implanted into a…